Palliative care provision in Huntington's disease.
There is currently much interest regarding the needs of people affected by non-malignant disease and whether or not these are being met by palliative care services. The evidence available appears to support the conclusion that while there is a general inequality of access, some individuals with non-malignant conditions such as cardiac disease and motor neurone disease are able to access palliative care services more readily than others. Huntington's disease (HD) is a devastating neurological condition of long duration and as such may have a lengthy palliative phase. Consequently, a diagnosis of HD will have a major impact on the quality of life of the affected individual and their family. For carers, an understanding of this challenging disease and its prognosis is essential for the provision of appropriate and effective care. This article reviews the links between HD and palliative care and discusses some of the challenges facing patients, families and health care professionals in adopting a palliative approach in the management of the disease.
Travers
Elizabeth
E
Marie Curie Cancer Centre, Marie Curie Hospice, Glasgow. Liz.Travers@mariecurie.org.uk
Jones
Kate
K
Nichol
Jacqueline
J
D000359:Aftercare / Q000458:organization & administration; D019317:Evidence-Based Medicine; D005190:Family / Q000523:psychology; D006297:Health Services Accessibility / Q000458:organization & administration; D006301:Health Services Needs and Demand / Q000458:organization & administration*; D006801:Humans; D006816:Huntington Disease / Q000453:epidemiology / Q000523:psychology / Q000628:therapy*; D008134:Long-Term Care; D010166:Palliative Care / Q000458:organization & administration*; D010347:Patient Care Planning / Q000458:organization & administration; D011379:Prognosis; D011788:Quality of Life; D012606:Scotland / Q000453:epidemiology; D012944:Social Support; D013222:State Medicine / Q000458:organization & administration